Cargando…
Non-coding RNA in drug resistance of gastric cancer
Gastric cancer (GC) is the third leading cause of cancer-related mortality worldwide. The poorly prognosis and survival of GC are due to diagnose in an advanced, non-curable stage and with a limited response to chemotherapy. The acquisition of drug resistance accounts for the majority of therapy fai...
Autores principales: | Luo, Ya-Jun, Huang, Qing-Mei, Ren, Yan, Liu, Zi-Lin, Xu, Cheng-Fei, Wang, Hao, Xiao, Jiang-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883183/ https://www.ncbi.nlm.nih.gov/pubmed/31798777 http://dx.doi.org/10.4251/wjgo.v11.i11.957 |
Ejemplares similares
-
Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance
por: Liu, Ying, et al.
Publicado: (2022) -
Decreased expression of the long non-coding RNA HOXD-AS2 promotes gastric cancer progression by targeting HOXD8 and activating PI3K/Akt signaling pathway
por: Yao, Lin, et al.
Publicado: (2020) -
Non-coding RNA in drug resistance of hepatocellular carcinoma
por: Ding, Bisha, et al.
Publicado: (2018) -
Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance
por: Yuan, Li, et al.
Publicado: (2020) -
Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review)
por: Chen, Chao, et al.
Publicado: (2019)